Varex Imaging (NASDAQ:VREX) Given Average Recommendation of “Moderate Buy” by Analysts

Varex Imaging (NASDAQ:VREX) has been given a consensus recommendation of “Moderate Buy” by the five research firms that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $16.1667.

Several analysts recently commented on VREX shares. Wall Street Zen lowered shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research note on Wednesday. Finally, Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th.

Institutional Trading of Varex Imaging

Several institutional investors and hedge funds have recently added to or reduced their stakes in VREX. Empowered Funds LLC lifted its stake in Varex Imaging by 7.3% during the first quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock valued at $2,078,000 after purchasing an additional 12,151 shares during the last quarter. Jane Street Group LLC lifted its stake in Varex Imaging by 17.9% during the first quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock valued at $1,849,000 after purchasing an additional 24,160 shares during the last quarter. Rhumbline Advisers lifted its stake in Varex Imaging by 4.6% during the second quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock valued at $536,000 after purchasing an additional 2,694 shares during the last quarter. Hsbc Holdings PLC lifted its stake in Varex Imaging by 19.7% during the second quarter. Hsbc Holdings PLC now owns 47,525 shares of the company’s stock valued at $408,000 after purchasing an additional 7,825 shares during the last quarter. Finally, Quantbot Technologies LP lifted its stake in Varex Imaging by 25.1% during the second quarter. Quantbot Technologies LP now owns 47,292 shares of the company’s stock valued at $410,000 after purchasing an additional 9,476 shares during the last quarter.

Varex Imaging Stock Performance

Shares of NASDAQ:VREX opened at $10.29 on Monday. The company has a 50 day moving average of $10.71 and a 200-day moving average of $11.81. The firm has a market cap of $433.21 million, a P/E ratio of -5.15 and a beta of 0.91. Varex Imaging has a twelve month low of $6.76 and a twelve month high of $14.56. The company has a current ratio of 3.20, a quick ratio of 1.43 and a debt-to-equity ratio of 0.67.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The company had revenue of $216.00 million during the quarter, compared to analyst estimates of $216.92 million. Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%.Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. As a group, analysts anticipate that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.